The acquisition of Proscia is intended to offer AI-enabled synergies with Agilent Technologies' companion diagnostics business in drug discovery and clinical research.

Aa19c345aTopic

AI

Artificial intelligence research, products, and impact across society.

12 debates·11,642 claims·218 news stories

0